Paid Clinical Trials in La Jolla, CA
As of August 2026, 536 paid clinical trials are recruiting in La Jolla, California. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
La Jolla offers studies at sites including UC San Diego Moores Cancer Center for conditions such as Breast Cancer, Prostate Cancer, Colorectal Cancer, Ovarian Cancer. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in La Jolla
Trials by drug in La Jolla
Filter results
Newly added in La Jolla
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
Behavioral Interventions Combining AI/ML and Personalized Medicine to Reduce Cardiovascular Risk - Randomized Controlled Trial
Effect of Anti-inflammatory Diet in Systemic Lupus Erythematous
Digital and Plasma Biomarkers in Delirium
Identifying Biomarkers Related to Opioid Use and Pain Response Following Traumatic Injury and Surgery
Precision Pain Management - A Randomized Clinical Trial Assessing the Efficacy of Suzetrigine on Postoperative Analgesia Among Surgical Patients at Higher Risk for Persistent Postoperative Opioid Use (POU)
476 clinical trials
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
An Evaluation of the Safety and Efficacy of TSND-201 for the Treatment of PTSD (EMPOWER-1)
Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH)
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
Parasternal Extravascular ICD System Pivotal Clinical Investigation (ALARION EV) Study
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
A Study of Pasritamig Versus Placebo in Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer
A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)
A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults
Assessment of CCM in HF With Higher Ejection Fraction
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
A Study to Evaluate the Safety and Efficacy of BGB-16673 Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
Top Research Study Locations in La Jolla
Researchers run research studies in La Jolla, CA at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| UC San Diego Moores Cancer Center | Stage IV Lung Cancer AJCC v8, Metastatic Malignant Solid Neoplasm, Stage IVB Prostate Cancer AJCC v8 | 84 |
| University of California San Diego | Amyotrophic Lateral Sclerosis, Cancer, Colorectal Cancer | 58 |
| University of California, San Diego | Prostate Cancer, Breast Cancer, Danon Disease | 52 |
| UC San Diego | Aortic Aneurysm, Abdominal, Becker Muscular Dystrophy, COVID -19 | 16 |
| Scripps Health | Aortic Insufficiency, Aortic Regurgitation, Aortic Valve Insufficiency | 13 |
| UCSD Moores Cancer Center | Cancer, CRC, Colon Cancer | 11 |
| UC San Diego Health | Heart Failure, Ventricular Fibrillation, Central Nervous System Lymphoma | 9 |
| Altman Clinical and Translational Research Institute | Chronic Low-back Pain, Complex Regional Pain Syndrome, Healthy Participants Study | 6 |
| UCSD | Advanced/Metastatic Solid Tumors, Bipolar Disorder, Colorectal Cancer | 6 |
| University of California San Diego Moores Cancer Center | Advanced Solid Tumor, Cervical Cancer, Metastatic Castration-resistant Prostate Cancer | 6 |
| Clinical Trial Site | ATTR Amyloidosis, Advanced Hepatocellular Carcinoma, High Cardiovascular Risk | 5 |
| Kadima Neuropsychiatry Institute | Major Depressive Disorder, Depression, Depressive Disorder, Treatment-Resistant | 5 |
| Scripps Clinic Torrey Pines | Carcinoma, Hepatocellular, Colitis, Ulcerative, Colorectal Cancer Metastatic | 5 |
| Scripps Green Hospital | Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML or ANLL), Acute Myeloid Leukemia Refractory | 5 |
| Scripps Memorial Hospital | Acute Decompensated Heart Failure, Coronary Arterial Disease (CAD), Heart Failure - NYHA II - IV | 5 |
| Scripps Translational Science Institute | Coronary Artery Disease, Healthy, Heart Diseases | 5 |
| University of California San Diego Medical Center | Alzheimers Disease, Alzheimers Disease, Familial, Dementia | 5 |
| Moores Cancer Center | Neoplasm Metastasis, Advanced Breast Cancer, Advanced Ovarian Cancer | 4 |
| Shiley Center for Orthopaedic Research and Education at Scripps Clinic | Adult Spinal Deformity, Kyphosis, Scoliosis | 4 |
| University of California at San Diego | Carcinoma, Non-small-Cell Lung, Hemolytic Disease of the Fetus and Newborn, Metastatic Castration-resistant Prostate Neoplasms | 4 |
| University of California, San Diego Moores Cancer Center | Basal Cell Carcinoma, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer | 4 |
| GSK Investigational Site | Gastrointestinal Neoplasms, Neoplasms, Prostate, Tumours, Gynecological | 3 |
| Kaizen Brain Center | Agitation, Alzheimer Disease, Chronic Migraine | 3 |
| Scripps Memorial Hospital La Jolla | Aortic Valve Disease Mixed, Aortic Valve Regurgitation, Heart Failure | 3 |
| UC San Diego Altman Clinical and Translational Research Institute | Anorexia Nervosa, Cardiometabolic Syndrome, Drug Interactions | 3 |
Active & Upcoming Studies in La Jolla (2026)
Recruiting trials in La Jolla grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (187 active studies)
- Neu Direction: Testing the Efficacy of Adding HER Inhibition to Standard of Care in Metastatic MLH1-low Endocrine-resistant ER+/HER2- Breast Cancer · Phase 2 · University of California, San Diego
- Signatera Assessment in Early-Stage Endometrial Cancer · Natera, Inc.
Neurology & pain (43 active studies)
- Identifying Biomarkers Related to Opioid Use and Pain Response Following Traumatic Injury and Surgery · University of California, San Diego
- Digital Lifestyle Coaching for Alzheimer's Disease Prevention in APOE4 Carriers · Scripps Translational Science Institute
Cardiovascular (31 active studies)
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
- Behavioral Interventions Combining AI/ML and Personalized Medicine to Reduce Cardiovascular Risk - Randomized Controlled Trial · National Bureau of Economic Research, Inc.
Diabetes & metabolic (22 active studies)
- Time Restricted Eating in Patients With Microalbuminuria · Phase 1 · University of California, San Diego
- Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1) · Phase 3 · Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
Mental health & behavior (13 active studies)
- Frontal Gamma Coherence Neurofeedback for Patients With Schizophrenia · BioSignal Solutions LLC
- RE104 Safety and Efficacy Study in Generalized Anxiety Disorder · Phase 2 · Reunion Neuroscience Inc
HIV / STI (8 active studies)
- Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy · International Maternal Pediatric Adolescent AIDS Clinical Trials Group
- An mHealth Intervention to Improve HIV Prevention Service Engagement Among People Who Use Drugs · University of California, San Diego
Eye & vision (8 active studies)
- Study of Serine Supplementation to Protect Vision in MacTel · Phase 3 · The Lowy Medical Research Institute Limited
- The Effectiveness of Systane PRO Preservative Free Verses Blink Triple Care Preservative Free · Phase 4 · Gordon Schanzlin New Vision
Vaccines (4 active studies)
- Preparedness Through Respiratory Virus Epidemiology and Community Engagement · University of California, San Diego
- A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised · Phase 3 · Pfizer
Pediatric (2 active studies)
- Flow and Grow - The Ideal Time to Wean CPAP Off In Extremely Low Birth Weight Infants · University of California, San Diego
- Randomized Study in Children and Adolescents With Migraine: Acute Treatment · Phase 3 · Pfizer
Common conditions studied in La Jolla
- Breast Cancer (14 active studies)
- Prostate Cancer (12 active studies)
- Colorectal Cancer (11 active studies)
- Ovarian Cancer (11 active studies)
- Advanced Solid Tumor (10 active studies)
- Heart Failure (10 active studies)
Leading research sponsors in La Jolla
- University of California, San Diego
- National Cancer Institute (NCI)
- AstraZeneca
- Eli Lilly and Company
- NRG Oncology
Frequently asked questions
How many paid clinical trials are currently recruiting in La Jolla?
There are approximately 536 recruiting clinical trials in La Jolla, California listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in La Jolla pay participants?
Most recruiting trials in La Jolla compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in La Jolla?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in La Jolla?
The most common conditions under active study in La Jolla include Breast Cancer (14), Prostate Cancer (12), Colorectal Cancer (11), Ovarian Cancer (11), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in La Jolla?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in La Jolla on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in La Jolla?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in La Jolla?
Recruiting research sites in La Jolla include UC San Diego Moores Cancer Center, University of California San Diego, University of California, San Diego, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in La Jolla right now?
The largest active categories in La Jolla are Cancer & tumors (187), Neurology & pain (43), Cardiovascular (31). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.